The Dysexecutive Syndrome of Alzheimer's Disease: the GREFEX Study
Overview
Neurology
Authors
Affiliations
Background: Dysexecutive disorders are common in early-stage Alzheimer's disease (AD) but have yet to be characterized in detail.
Objective: The objectives of the present study based on validated diagnostic criteria were to determine the frequency and characterize the profile of behavioral and cognitive dysexecutive disorders in AD.
Methods: 102 patients with AD (mild: n = 92; moderate: n = 10; mean MMSE score: 23.2) were examined with the GREFEX battery. Neuropsychological data were interpreted within a validated framework based on the performance levels of 780 control participants from the GREFEX study.
Results: Dysexecutive syndrome was observed in 87.5% (95%CI: 79-96) of the AD patients (p = 0.0001). The dysexecutive disorder profile was characterized by prominent impairments of planning, inhibition flexibility and generation in the cognitive domain (p = 0.0001 as compared to controls for all) and global hypoactivity in the behavioral domain (p = 0.0001 as compared to controls).
Conclusions: Dysexecutive syndrome is observed in over 80% of AD patients and has a distinct profile.
Godefroy O, Aarabi A, Bejot Y, Biessels G, Glize B, Mok V Eur Stroke J. 2024; :23969873241271651.
PMID: 39129252 PMC: 11569528. DOI: 10.1177/23969873241271651.
Godefroy O, Weaver N, Roussel M, Dorchies F, Kassir R, Biesbroek J J Neurol. 2024; 271(9):6147-6159.
PMID: 39060618 DOI: 10.1007/s00415-024-12541-8.
Ben Ayed I, Ammar A, Boujelbane M, Salem A, Naija S, Ben Amor S Diseases. 2024; 12(7).
PMID: 39057119 PMC: 11275411. DOI: 10.3390/diseases12070148.
Dysexecutive Behavior in First-Episode Schizophrenia.
Orellana G, Slachevsky A, Henriquez F Clin Schizophr Relat Psychoses. 2023; 16(Suppl 3).
PMID: 37101576 PMC: 10129061.
Frank B, Ally M, Tripodis Y, Puzo C, Labriola C, Hurley L Neurology. 2022; 98(24):e2454-e2464.
PMID: 35444054 PMC: 9231841. DOI: 10.1212/WNL.0000000000200304.